Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Estelle

Showing results (71-80 of 165) with videos related to

Pageof 17
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2014
H2-antihistamines for the treatment of anaphylaxis with and without shock: a systematic reviewUlugbek B Nurmatov, Edmund Rhatigan, F Estelle R Simons, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Auvi-Q versus EpiPen: preferences of adults, caregivers, and childrenCarlos A Camargo, Adriana Guana, Sheldon Wang, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 22, 2004
Evidence for natural desensitization to mosquito salivary allergens: mosquito saliva specific IgE and IgG levels in childrenZhikang Peng, Man Ki Ho, Caihe Li, et al.
Drug Development and Industrial Pharmacy|May 24, 2007
Fast-disintegrating sublingual epinephrine tablets: effect of tablet dimensions on tablet characteristicsMutasem M Rawas-Qalaji, F Estelle R Simons, Keith J Simons
Biopharmaceutics & Drug Disposition|September 30, 2006
Epinephrine for the treatment of anaphylaxis: do all 40 mg sublingual epinephrine tablet formulations with similar in vitro characteristics have the same bioavailability?Mutasem M Rawas-Qalaji, F Estelle R Simons, Keith J Simons
The Journal of Allergy and Clinical Immunology|February 8, 2006
Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxisMutasem M Rawas-Qalaji, F Estelle R Simons, Keith J Simons
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Caregivers' perspectives on timing the transfer of responsibilities for anaphylaxis recognition and treatment from adults to children and teenagersElinor Simons, Scott H Sicherer, Christopher Weiss, et al.
AAPS Pharmscitech|April 28, 2011
Dissolution testing of sublingual tablets: a novel in vitro methodOusama Rachid, Mutasem Rawas-Qalaji, F Estelle R Simons, et al.
The Cochrane Database of Systematic Reviews|October 10, 2008
Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shockAziz Sheikh, Yasser A Shehata, Simon Ga Brown, et al.
AAPS Pharmscitech|March 31, 2010
An electronic tongue: evaluation of the masking efficacy of sweetening and/or flavoring agents on the bitter taste of epinephrineOusama Rachid, F Estelle R Simons, Mutasem Rawas-Qalaji, et al.
Pageof 17

Showing results (71-80 of 165) with videos related to

Sort By:
Pageof 17
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2014
H2-antihistamines for the treatment of anaphylaxis with and without shock: a systematic reviewUlugbek B Nurmatov, Edmund Rhatigan, F Estelle R Simons, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Auvi-Q versus EpiPen: preferences of adults, caregivers, and childrenCarlos A Camargo, Adriana Guana, Sheldon Wang, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 22, 2004
Evidence for natural desensitization to mosquito salivary allergens: mosquito saliva specific IgE and IgG levels in childrenZhikang Peng, Man Ki Ho, Caihe Li, et al.
Drug Development and Industrial Pharmacy|May 24, 2007
Fast-disintegrating sublingual epinephrine tablets: effect of tablet dimensions on tablet characteristicsMutasem M Rawas-Qalaji, F Estelle R Simons, Keith J Simons
Biopharmaceutics & Drug Disposition|September 30, 2006
Epinephrine for the treatment of anaphylaxis: do all 40 mg sublingual epinephrine tablet formulations with similar in vitro characteristics have the same bioavailability?Mutasem M Rawas-Qalaji, F Estelle R Simons, Keith J Simons
The Journal of Allergy and Clinical Immunology|February 8, 2006
Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxisMutasem M Rawas-Qalaji, F Estelle R Simons, Keith J Simons
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Caregivers' perspectives on timing the transfer of responsibilities for anaphylaxis recognition and treatment from adults to children and teenagersElinor Simons, Scott H Sicherer, Christopher Weiss, et al.
AAPS Pharmscitech|April 28, 2011
Dissolution testing of sublingual tablets: a novel in vitro methodOusama Rachid, Mutasem Rawas-Qalaji, F Estelle R Simons, et al.
The Cochrane Database of Systematic Reviews|October 10, 2008
Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shockAziz Sheikh, Yasser A Shehata, Simon Ga Brown, et al.
AAPS Pharmscitech|March 31, 2010
An electronic tongue: evaluation of the masking efficacy of sweetening and/or flavoring agents on the bitter taste of epinephrineOusama Rachid, F Estelle R Simons, Mutasem Rawas-Qalaji, et al.
Pageof 17